RxDoctor Payments DataLook up a doctor →

Deryk Jones, MD

Sports Medicine · San Carlos, CANPI 1356390611

Payments from drug & device makers

$1,552,728in general payments, 2019–2025

Across 673 payments — averaging $2307.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vericel Corporation$360K
  • Linvatec Corporation$337K
  • Medical Device Business Services, Inc.$209K
  • Endo Pharmaceuticals Inc.$155K
  • Biotissue Holdings Inc.$108K
  • Smith+Nephew$88K
  • plus $296K from 30 others
$176,781in research payments, 2019–2025

Across 25 payments — averaging $7071.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Linvatec Corporation$166K
  • Episurf Medical, Inc.$11K

What the payments were for

  • Consulting fees$411,20645%
  • Speaking & faculty fees$181,80020%
  • Grants$38,9974%
  • Travel & lodging$56,5536%
  • Food & beverage$17,9152%
  • Education$1,2000%
  • Entertainment$190%
  • Other$207,80923%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,552,728 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California

Medicare billing

Part B allowed, 2024
$29,947
Medicare patients
60
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib114$2,430
Methocarbamol36$422
Pregabalin28$246
Meloxicam62$199
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$151
Gabapentin17$106

Paid to pharmacies, not to this prescriber.

Other sports medicine in San Carlos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →